• Effect Of Hepatosteatosis On The Virological Response In Entecavir And Tenofovir Therapies 

      Korkmaz, Pinar; Demirturk, Nese; Batirel, Ayse; Tulek, Necla; Ozguler, Muge; Harman, Rezan; Cinar, Gule; Toka, Onur; Yoruk, Gulsen; Ataman-Hatipoglu, Cigdem; Sarigul, Figen; Sirmatel, Fatma; Imre, Ayfer; Mistanoglu-Ozatag, Duru; Karakecili, Faruk; Ural, Onur; Sumer, Sua; Aktug-Demir, Nazlim; Kadanali, Ayten; Comoglu, Senol; Ucer, Sengul; Saltoglu, Nese; Gunal, Ozgur; Ozkaya, Hacer Deniz; Yenilmez, Ercan; Cetinkaya, Riza Aytac; Yuksel, Esma; Hakyemez, Ismail Necati; Meric-Koc, Meliha; Tuncer-Ertem, Gunay; Bestepe-Dursun, Zehra; Celik, Ilhami; Yilmaz, Emel; Evik, Guliz; Kaya, Ali; Suer, Kaya (2019)
      Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine ...